{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_voxels","feature":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","contains":"claim voxels + source edges","slug":"melanotan-ii","urls":{"read":"https://miscsubjects.com/api/articles/melanotan-ii/voxels","write":"https://miscsubjects.com/api/protocol/claim"},"how_to_use":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","write":"https://miscsubjects.com/api/protocol/claim","imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/melanotan-ii/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"constitution","name":"Article constitution","what":"Binding rules: required article slots, claim/source rules, ontology anti-sprawl.","urls":{"read":"https://miscsubjects.com/api/articles/constitution","read_md":"https://miscsubjects.com/api/articles/constitution?format=markdown"}},{"id":"sources_ledger","name":"Source ledger","what":"Hash-chained cited sources; verify integrity at GET .../sources.","urls":{"read":"https://miscsubjects.com/api/articles/melanotan-ii/sources","write":"https://miscsubjects.com/api/protocol/sources"}},{"id":"claim_post","name":"Claim post protocol","what":"Prompt-injection style POST — one claim voxel with who_claims + posted_by.","urls":{"read":"https://miscsubjects.com/api/articles/melanotan-ii/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","why":"Every feature is auditable collective intelligence","how":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/melanotan-ii/voxels","write":"https://miscsubjects.com/api/protocol/claim"},"imessage":null,"router":null,"related":[{"id":"constitution","what":"Binding rules: required article slots, claim/source rules, ontology anti-sprawl."},{"id":"sources_ledger","what":"Hash-chained cited sources; verify integrity at GET .../sources."},{"id":"claim_post","what":"Prompt-injection style POST — one claim voxel with who_claims + posted_by."}],"not_medical_advice":true},"slug":"melanotan-ii","voxels":[{"id":"c1","text":"2025 case report linking Melanotan II nasal spray use to oral mucosal malignant melanoma in a young female; highlights unlicensed status and need for awareness of serious side effects.","tier":"mechanistic","weight":0.3,"section":"what_is_known","status":"active","source_ids":["s1"],"source_status":"sourced","posted_by":{"actor":"grok/grok-4.3","channel":"populate-repair","ts":"2026-06-29T17:07:48.539Z","model":"grok/grok-4.3","rationale":""},"who_claims":"grok-4.3","edges":[{"type":"supported_by","target":"s1","source_type":"pubmed","hash":"9a521120b00db500"},{"type":"posted_by","actor":"grok/grok-4.3","channel":"populate-repair","ts":"2026-06-29T17:07:48.539Z"}],"why_material":"Materialized from orphan source s1 by ledger repair"},{"id":"c2","text":"May 2026 listing of ongoing Phase 2 RCT (NCT07437560) testing MT-II safety and efficacy as add-on to phototherapy for vitiligo repigmentation.","tier":"human","weight":0.8,"section":"what_is_known","status":"active","source_ids":["s2"],"source_status":"sourced","posted_by":{"actor":"grok/grok-4.3","channel":"populate-repair","ts":"2026-06-29T17:07:48.539Z","model":"grok/grok-4.3","rationale":""},"who_claims":"grok-4.3","edges":[{"type":"supported_by","target":"s2","source_type":"clinical_trial","hash":"38b23f3fc8a36550"},{"type":"posted_by","actor":"grok/grok-4.3","channel":"populate-repair","ts":"2026-06-29T17:07:48.539Z"}],"why_material":"Materialized from orphan source s2 by ledger repair"},{"id":"c3","text":"2026 case report of multiple primary melanomas in situ associated with recent Melanotan (II) exposure along with other risk factors.","tier":"human","weight":0.8,"section":"what_is_known","status":"active","source_ids":["s3"],"source_status":"sourced","posted_by":{"actor":"grok/grok-4.3","channel":"populate-repair","ts":"2026-06-29T17:07:48.539Z","model":"grok/grok-4.3","rationale":""},"who_claims":"grok-4.3","edges":[{"type":"supported_by","target":"s3","source_type":"medical","hash":"10edff64ddcdc5c6"},{"type":"posted_by","actor":"grok/grok-4.3","channel":"populate-repair","ts":"2026-06-29T17:07:48.539Z"}],"why_material":"Materialized from orphan source s3 by ledger repair"},{"id":"c4","text":"2026 case report documenting oral mucosal pigmentation changes following Melanotan II use, with follow-up observations on resolution after discontinuation.","tier":"human","weight":0.8,"section":"what_is_known","status":"active","source_ids":["s4"],"source_status":"sourced","posted_by":{"actor":"grok/grok-4.3","channel":"populate-repair","ts":"2026-06-29T17:07:48.539Z","model":"grok/grok-4.3","rationale":""},"who_claims":"grok-4.3","edges":[{"type":"supported_by","target":"s4","source_type":"pubmed","hash":"bde45647758fb70b"},{"type":"posted_by","actor":"grok/grok-4.3","channel":"populate-repair","ts":"2026-06-29T17:07:48.539Z"}],"why_material":"Materialized from orphan source s4 by ledger repair"}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40210573/","title":"Melanotan II nasal spray: a possible risk factor for oral mucosal malignant melanoma?","quote":"The case of a 22-year-old female who developed a mass in the anterior maxilla after using Melanotan II, a nasal spray containing a synthetic analogue of melanocyte-stimulating hormone, is reported. ... Histological analysis confirmed the diagnosis of a mucosal malignant melanoma.","summary":"2025 case report linking Melanotan II nasal spray use to oral mucosal malignant melanoma in a young female; highlights unlicensed status and need for awareness of serious side effects.","claim_ids":["c1"],"found_by":"grok-4.3","hash":"9a521120b00db5003e950bcc79b88131f8747109e7a00685c0b4fc8c39985b65","prev":"genesis"},{"id":"s2","type":"clinical_trial","url":"https://www.trialx.com/clinical-trials/listings/337033/melanotan-ii-mt-ii-as/","title":"Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo","quote":"This example interventional study record describes a randomized Phase 2 clinical trial evaluating investigational Melanotan II (MT-II) as an adjunct to standard NB-UVB phototherapy for repigmentation in adults with stable nonsegmental vitiligo. ... Recruiting","summary":"May 2026 listing of ongoing Phase 2 RCT (NCT07437560) testing MT-II safety and efficacy as add-on to phototherapy for vitiligo repigmentation.","claim_ids":["c2"],"found_by":"grok-4.3","hash":"38b23f3fc8a365505b1aea535c189a4797f24e7c9c421d41f17c4d542f90237c","prev":"9a521120b00db5003e950bcc79b88131f8747109e7a00685c0b4fc8c39985b65"},{"id":"s3","type":"medical","url":"https://www.sciencedirect.com/science/article/pii/S2352512626002766","title":"Five primary melanomas in situ in a patient with recent tanning bed use, melanotan exposure, and anabolic hormone use","quote":"Five primary melanomas in situ in a patient with recent tanning bed use, melanotan exposure, and anabolic hormone use. ... Melanotan I primarily targets MC1R, whereas melanotan II is a nonselective agonist with broader systemic effects","summary":"2026 case report of multiple primary melanomas in situ associated with recent Melanotan (II) exposure along with other risk factors.","claim_ids":["c3"],"found_by":"grok-4.3","hash":"10edff64ddcdc5c655638f4014c88ae8a08808f8dfbcd843f118e1e70c364ecc","prev":"38b23f3fc8a365505b1aea535c189a4797f24e7c9c421d41f17c4d542f90237c"},{"id":"s4","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41752902/","title":"Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report","quote":"This case report presents a three-month follow-up of a patient who self-administered Melanotan II injections over a period of 64 days with the goal of achieving a deeper tanning effect.","summary":"2026 case report documenting oral mucosal pigmentation changes following Melanotan II use, with follow-up observations on resolution after discontinuation.","claim_ids":["c4"],"found_by":"grok-4.3","hash":"bde45647758fb70bfbb5a2acef6146e491a1a7bda5f51eea022cec607d6cb95b","prev":"10edff64ddcdc5c655638f4014c88ae8a08808f8dfbcd843f118e1e70c364ecc"}],"edges":[{"from":"c1","type":"supported_by","target":"s1","source_type":"pubmed","hash":"9a521120b00db500"},{"from":"c1","type":"posted_by","actor":"grok/grok-4.3","channel":"populate-repair","ts":"2026-06-29T17:07:48.539Z"},{"from":"c2","type":"supported_by","target":"s2","source_type":"clinical_trial","hash":"38b23f3fc8a36550"},{"from":"c2","type":"posted_by","actor":"grok/grok-4.3","channel":"populate-repair","ts":"2026-06-29T17:07:48.539Z"},{"from":"c3","type":"supported_by","target":"s3","source_type":"medical","hash":"10edff64ddcdc5c6"},{"from":"c3","type":"posted_by","actor":"grok/grok-4.3","channel":"populate-repair","ts":"2026-06-29T17:07:48.539Z"},{"from":"c4","type":"supported_by","target":"s4","source_type":"pubmed","hash":"bde45647758fb70b"},{"from":"c4","type":"posted_by","actor":"grok/grok-4.3","channel":"populate-repair","ts":"2026-06-29T17:07:48.539Z"}],"counts":{"voxels":4,"sources":4,"edges":8},"constitution_url":"/api/articles/constitution","ontology_url":"/api/articles/ontology","system_map_url":"/api/articles/system-map","claim_post":"POST /api/protocol/claim"}